28/06/2026
โจ Recent research, published in the Journal of Alzheimerโs Disease, indicates that microdosing cannabis extract holds promise for slowing cognitive decline in patients with mild Alzheimerโs disease.
Researchers attribute potential benefits to cannabinoids' multi-target effects, including reducing neuroinflammation, combating oxidative stress, modulating the endocannabinoid system (which declines with age and supports neuroprotection), and possibly influencing amyloid plaque clearance or synaptic healthโkey factors in Alzheimerโs progression.๐ฟ
While not a cure, these findings offer hope for a novel, low-risk adjunctive approach in managing this devastating condition.๐
๐ Via Science Acumen
https://www.facebook.com/share/1CGDF6qeii/